Table 2 Change between baseline and week 24 for secondary outcomes
Omega three | Control | Mean difference (Omega three minus Control) | p | |
|---|---|---|---|---|
Weight (kg) | 0.23 (0.49) | − 0.05 (0.46) | 0.28 (− 1.09 to 1.65) | 0.68 |
BMI (kg/m2) | − 0.01 (0.16) | 0.03 (0.15) | − 0.04 (− 0.419 to 0.41) | 0.86 |
eGFR (ml/min/1.73m2) | − 2.7 (1.5) | − 1.5 (1.4) | − 1.2 (− 5.3 to 2.9) | 0.56 |
Cholesterol (mmol/l) | 0.23 (0.13) | − 0.11 (0.12) | 0.34 (− 0.03 to 0.71) | 0.07 |
Triglycerides (mmol/l) | − 0.38 (0.18) | − 0.16 (0.16) | − 0.22 (− 0.71 to 0.27) | 0.37 |
HDL (mmol/l) | 0.07 (0.04) | 0.02 (0.04) | 0.05 (− 0.07 to 0.18) | 0.39 |
LDL (mmol/l) | 0.31 (0.11) | − 0.06 (0.10) | 0.37 (0.07 to − 0.66) | 0.02 |
Cholesterol (total/LDL) | 0.06 (0.19) | − 0.09 (0.18) | 0.15 (− 0.37 to 0.67) | 0.57 |
HbA1c (mmol/mol) | 1.08 (1.0) | 0.77 (0.92) | 1.85 (− 0.94 to 4.64) | 0.19 |
Oxypurinol(µmol/l) | − 2.2 (10.9) | 12.7 (9.7) | − 14.9 (− 47.3 to 17.4) | 0.34 |
Total omega 3 (%) | 5.69 (0.57) | 0.38 (0.53) | 5.31 (3.72 to 6.90) | < 0.001 |
20:5n-3 (EPA)% | 2.90 (0.34) | − 0.04 (0.32) | 2.93 (1.99 to 3.88) | < 0.001 |
22:6n-3 (DHA)% | 2.15 (0.23) | 0.14 (0.22) | 2.01 (1.36 to 2.67) | < 0.001 |